several years have shown a persistence of their instability even when the symptoms have been improved by drugs or surgery (Arnold et al., 1973; Brown, 1973) .
The treatment claimed to train the enuretic child to wake at night before passage of water occurs results in enuresis being replaced either by nocturia, which in diurnal plus nocturnal cases will be accompanied by frequency, urgency, and threatened urge incontinence, or, in nocturnal cases only, by complete cure. Our patients who had dry episodes confirmed this; a change of locus and environment may cause sudden temporary disappearance of nocturnal enuresis with subsequent return. "It never troubles me on holiday," remarked one of our male nocturnal enuretics aged 25; "when I go to camp with the school I am dry," said a 16-year-old girl with nocturnal enuresis. Both these patients were normal on urodynamic study and had no daytime symptoms.
DEPTH OF SLEEP
Not only does the enuretic child exhibit uninhibited detrusor contractions during sleep but these fail to arouse him sufficiently to enable him to avert threatened leakage by contracting the external sphincter before visiting the lavatory. Furthermore, most enuretic children remain asleep despite this detrusor contraction; nor are the majority woken by the discomfort of lying in a wet bed. This contrasts with a child who occasionally wets the bed as a result of psychological or environmental change and who usually does wake up on wetting. These observations appear to lend support to the suggestion that enuretics sleep more deeply than do normal children. Electroencephalographic studies indicate that the enuretic episode typically occurs during non-rapid-eye-movement (N.R.E.M.) sleep and begins at deeper levels of sleep when there is decreased function in the reticular activating system, as discussed by Martin (1971) . At the deeper levels of N.R.E.M. sleep an increase in uninhibited spontaneous contractions has been shown. Nevertheless, the deep-sleep theory of enuresis received little support from controlled clinical research and experimental work (Kolvin and Taunch, 1973) . It seems, however, that in nocturnal plus diurnal (unstable) cases which it is hoped to convert to nocturia, alteration of the depth of sleep must be a factor in the success of any treatment.
Conclusion
Much of our thought has been stimulated by the work of many authors brought together in an excellent book which showed that our urodynamic findings fitted in well with the clinical observations. Much remains unanswered and we can only hope that urodynamics will make a small contribution to our knowledge. Dynamic examinations of the type described are indicated only when enuresis is persistent or differentiation of the clinical type is difficult.
Introduction
The diagnosis of deep vein thrombosis (D.V.T.) of the lower limb is notoriously difficult to make on clinical grounds alone, and for this reason ascending venography and the 125I-fibrinogen uptake test (Atkins and Hawkins, 1965; Kakkar et al., 1970) have become invaluable aids. Several attempts have been made to find a laboratory test which would identify patients with incipient or established venous thrombosis (Fletcher et al., 1972; Flute et al., 1972; Gurewich, 1972) , but none have produced an investigation which is both simple and reliable.
Immunologically detectable fibrinogen-fibrin-related antigen* (F.R.-antigen) in serum is presumed to arise from the proteolysis of fibrinogen or fibrin (Ferreira and Murat, 1963) . Raised serum levels of F.R.-antigen appear in the presence of systemically increased fibrinolytic activity and in states where either disseminated or localized intravascular coagulation occur (Merskey et al., 1966) .
Several investigators have evaluated serum F.R.-antigen levels in the diagnosis of D.V.T of the lower limbs (Ruckley et al., 1970; Wood et al., 1972; Gurewich et al., 1973) . Those studied have mostly been in patients, especially postoperative cases, and here the value of F.R.-antigen measurement has remained controversial. We have investigated the possible use of this index in patients referred from home by their own general practitioners with provisional primary diagnosis of D.V.T.
Patients and Methods
Altogether 129 patients referred to hospital with a primary clinical diagnosis of D.V.T. of the lower limb were studied. A specimen of venous blood was taken with the minimum of venous occlusion and 1 ml was added to a tube containing 0-05 ml (25 Kallikrein inactivator units) of aprotinin (Trasylol) and incubated for one hour at 37 C. The serum F.R.-antigen concentration was estimated by the latex flocculation inhibition method described by Allington (1971) using an antiserum directed against a late plasmin digest of fibrinogen (D and E fragments). Ascending venography was carried out, usually within two hours of admission. The patients were divided into four groups according to the extent of the thrombosis as shown by venography: group 1, no thrombus; group 2, calf or popliteal vein only; group 3, calf and popliteal veins or femoral veins only; group 4, calf, popliteal, and femoral veins, calf and femoral veins, or ileofemoral veins. Evidence of pulmonary embolism was assessed from clinical, chest x-ray, and electrocardiographic examination. All other diagnoses at the time of admission were noted.
The Mann-Whitney U test was used to estimate the significance of any difference in F.R.-antigen concentrations between groups, Student's t test for differences in ages, and the Spearnan rank correlation test to calculate the probability of a correlation between F.R.-antigen concentration and the length of clinical history. BRITISH MEDICAL JOURNAL 15 FEBRUARY 1975 venogram group (group 1) had similair F.R.-antigen levels. The mean (geometric) levels in these two groups, however, differed significantly from those in the more severely affected patients (see fig.) . The mean value of the serum F.R.-antigen did not differ significantly between groups 3 and 4. Co-existing pulmonary embolism might have affected the F.R.-antigen levels, and there was a greater proportion of patients with suspected embolism in the more severely affected groups 3 and 4 (21% and 18% respectively), but further analysis showed that these individuals did not noticeably bias the F.R.-antigen levels.
Inflammatory, traumatic, or malignant disease may also raise F.R.-antigen levels (Hedner and Nilsson, 1971) . Altogether 48 patients had such conditions: 16 had had recent surgery or injury, four had a torn calf muscle or haematoma, six had chest infection, two had had recent myocardial infarction, three had cellulitis, two had rheumatoid arthritis, two had prostatic carcinoma, two had diabetes mellitus, two had superficial phlebitis, and temporal arteritis, polymyalgia rheumatica, sarcoidosis, Wegener's granuloma, Crohn's disease, bronchial carcinoma, rectal carcinoma, myelomatosis, and chronic renal insufficiency were each present in one patient. When these patients were excluded from the analysis the difference between the groups was accentuated (P values for groups 1 v. 2 = 0-12; (table 1) though the mean age in group 4 was 10 years greater than that in group 1 (t = 2-72; P < 0-01). Also there was a preponderance of women in group 1, but neither age nor sex correlated with the serum F.R.-antigen levels.
Those patients with minor D.V.T. (group 2) and the negative Mean age (years)
44-8 ± 18 7 50-6 ± 15-6 45-4 ± 13 4 55 1 ± 16-8
Mean length of clinical history (days) 10 3 ± 11 1 7-1 ± 6-5 11-4 ± 22-9 10 3 ± 11-8 No. (%) with evidence of pulmonary embolism 1 (2) 1 (4) 3 (21) 8 (18) Mean F.R.-antigen (mg/l)* 2-9 ± 2-5 3 0 ± 2-7 7 7 ± 3-4 12-5 ± 3-3 * F.R.-antigen concentrations were estimated from "doubling dilutions" of serum so geometric mean values are stated.
* The term fibrinogen-fibrin-related antigen is used in preference to the more commonly used fibrin-fibrinogen degradation products (Merskey et al., 1971) as the material in serum may include small amounts of soluble fibrsn polymer and fibrin monomer in addition to the breakdown products. (Ruckley et al., 1970; Wood et al., 1972) and after myocardial infarction (Simmons et al., 1973) . In these cases F.R.-antigen is likely to be significantly raised as a result of the initial condition (Cash et al., 1969; Hedner and Nilsson, 1971) . A positive correlation between F.R.-antigen levels and acute pulmonary thromboembolism has been shown by several workers (Ruckley et al., 1970; Wilson et al., 1971; Rickman et al., 1973) . Associated pulmonary embolism must, therefore, be considered as a possible cause for excessive increases in F.R.-antigen in the presence of D.V.T. Several patients in this study were thought to have suffered such accidents (about 20% in groups 3 and 4) on clinical, electrocardiographic, and radiological grounds. As no further objective evidence of pulmonary embolism was sought this figure may be an underestimate. Nevertheless, these patients did not differ in their F.R.-antigen levels from those with no suspicion of pulmonary embolism.
The estimation of serum F.R.-antigen levels no longer requires expertise and is not time consuming. Latex flocculation inhibition (Diagen; Diagnosic Reagents, Thame) and direct agglutination of latex sensitized to fragments D and E (ThromboWellco test, Burroughs Wellcome Ltd.) are both straightforward and rapid techniques, and facilities for such tests are more likely to be available than venography in many institutions.
In the outpatient who develops clinical signs of D.V.T. a raised level of serum F.R.-antigen seems to be strong evidence in favour of the diagnosis of D.V.T. A normal serum F.R.-antigen level, however, does not exclude extensive thrombosis, and false positive results also occur. Though an F.R.-antigen level of 12 mg/l or above is virtually conclusive evidence of D.V.T. if other known causes of raised levels are absent the importance of objective techniques, especially venography, for diagnostic confirmation must be emphasized.
